Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome
Clinical trial NCT03337451 · COMPLETED
Trial details
- NCT number
- NCT03337451
- Sponsor
- Opsona Therapeutics Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-27
- Primary completion
- 2019-01-10
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.